Literature DB >> 21312347

Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus.

Laura J Julian1, Steven E Gregorich, Chris Tonner, Jinoos Yazdany, Laura Trupin, Lindsey A Criswell, Ed Yelin, Patricia P Katz.   

Abstract

OBJECTIVE: Identifying persons with systemic lupus erythematosus (SLE) at risk for depression would facilitate the identification and treatment of an important comorbidity conferring additional risk for poor outcomes. The purpose of this study was to determine the utility of a brief screening measure, the Center for Epidemiologic Studies Depression Scale (CES-D), in detecting mood disorders in persons with SLE.
METHODS: This cross-sectional study examined 150 persons with SLE. Screening cut points were empirically derived using threshold selection methods, and receiver operating characteristic curves were estimated. The empirically derived cut points of the CES-D were used as the screening measures and were compared to other commonly used CES-D cut points in addition to other commonly used methods to screen for depression. Diagnoses of major depressive disorder or other mood disorders were determined using a "gold standard" structured clinical interview.
RESULTS: Of the 150 persons with SLE, 26% of subjects met criteria for any mood disorder and 17% met criteria for major depressive disorder. Optimal threshold estimations suggested a CES-D cut score of 24 and above, which yielded adequate sensitivity and specificity in detecting major depressive disorder (88% and 93%, respectively) and correctly classified 92% of participants. To detect the presence of any mood disorder, a cut score of 20 and above was suggested, yielding sensitivity and specificity of 87% and correctly classifying 87%.
CONCLUSION: These results suggest the CES-D may be a useful screening measure to identify patients at risk for depression.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2011        PMID: 21312347      PMCID: PMC3719846          DOI: 10.1002/acr.20447

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  27 in total

1.  Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients.

Authors:  Brett D Thombs; Marie Hudson; Marielle Bassel; Suzanne S Taillefer; Murray Baron
Journal:  Arthritis Rheum       Date:  2009-07-15

2.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

3.  Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

Authors:  R L Brey; S L Holliday; A R Saklad; M G Navarrete; D Hermosillo-Romo; C L Stallworth; C R Valdez; A Escalante; I del Rincón; G Gronseth; C B Rhine; P Padilla; D McGlasson
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

4.  Endorsement of self-report neurovegetative items of depression is associated with multiple sclerosis disease symptoms.

Authors:  Joe E Beeney; Peter A Arnett
Journal:  J Int Neuropsychol Soc       Date:  2008-11       Impact factor: 2.892

5.  Screening for depression in adults: U.S. preventive services task force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-12-01       Impact factor: 25.391

6.  Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies.

Authors:  E W Karlson; L H Daltroy; C Rivest; R Ramsey-Goldman; E A Wright; A J Partridge; M H Liang; P R Fortin
Journal:  Lupus       Date:  2003       Impact factor: 2.911

7.  Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies.

Authors:  Fabiano G Nery; Eduardo F Borba; Vilma S T Viana; John P Hatch; Jair C Soares; Eloísa Bonfá; Francisco Lotufo Neto
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-11-19       Impact factor: 5.067

8.  Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors.

Authors:  K Baker; J Pope; P Fortin; E Silverman; C Peschken
Journal:  Lupus       Date:  2009-10-23       Impact factor: 2.911

9.  Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus.

Authors:  Pantelis Panopalis; Jinoos Yazdany; Joann Zell Gillis; Laura Julian; Laura Trupin; Aimee O Hersh; Lindsey A Criswell; Patricia Katz; Edward Yelin
Journal:  Arthritis Rheum       Date:  2008-12-15

10.  Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates.

Authors:  Katherine Milette; Marie Hudson; Murray Baron; Brett D Thombs
Journal:  Rheumatology (Oxford)       Date:  2010-01-25       Impact factor: 7.580

View more
  14 in total

1.  Depression and Progression of Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus.

Authors:  April Jorge; Apinya Lertratanakul; Jungwha Lee; William Pearce; David McPherson; Trina Thompson; Emma Barinas-Mitchell; Rosalind Ramsey-Goldman
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-11-21       Impact factor: 4.794

2.  Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated.

Authors:  Panagiota Anyfanti; Eleni Gavriilaki; Athina Pyrpasopoulou; George Triantafyllou; Areti Triantafyllou; Sofia Chatzimichailidou; Eugenia Gkaliagkousi; Spyros Aslanidis; Stella Douma
Journal:  Clin Rheumatol       Date:  2014-05-25       Impact factor: 2.980

3.  Prevalence and risk factors of anxiety and depression in patients with systemic lupus erythematosus in Southwest China.

Authors:  Xia Xie; Dongmei Wu; Hong Chen
Journal:  Rheumatol Int       Date:  2016-08-31       Impact factor: 2.631

Review 4.  Anxiety and Mood Disorders in Systemic Lupus Erythematosus: Current Insights and Future Directions.

Authors:  Annaliese Tisseverasinghe; Christine Peschken; Carol Hitchon
Journal:  Curr Rheumatol Rep       Date:  2018-11-12       Impact factor: 4.592

5.  Socioeconomic Predictors of Incident Depression in Systemic Lupus Erythematosus.

Authors:  Natalie Mccormick; Laura Trupin; Edward H Yelin; Patricia P Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-12-08       Impact factor: 4.794

6.  Depression Risk in Young Adults With Juvenile- and Adult-Onset Lupus: Twelve Years of Followup.

Authors:  Andrea M Knight; Laura Trupin; Patricia Katz; Edward Yelin; Erica F Lawson
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-03       Impact factor: 4.794

7.  Who receives contraception counseling when starting new lupus medications? The potential roles of race, ethnicity, disease activity, and quality of communication.

Authors:  S Ferguson; L Trupin; J Yazdany; E Yelin; J Barton; P Katz
Journal:  Lupus       Date:  2015-07-19       Impact factor: 2.911

8.  Patient-Reported Outcomes Predict Mortality in Lupus.

Authors:  Desiree R Azizoddin; Meenakshi Jolly; Shilpa Arora; Ed Yelin; Patricia Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-07-13       Impact factor: 4.794

9.  The Relationship Between Life Purpose With Depression and Disability in Acute Low Back Pain Patients.

Authors:  Elizabeth Salt; Amanda C Wiggins; Mary Kay Rayens; Rachele Johnson; Jaime K Hardy; Suzanne Segerstrom; Leslie J Crofford
Journal:  Orthop Nurs       Date:  2018 Sep/Oct       Impact factor: 0.913

10.  Prevalence and predictors of depression in patients with systemic lupus erythematosus: a cross-sectional study.

Authors:  Benchalak Maneeton; Narong Maneeton; Worawit Louthrenoo
Journal:  Neuropsychiatr Dis Treat       Date:  2013-06-05       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.